Gallagher Fiduciary Advisors LLC Sells 199 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

by · The Cerbat Gem

Gallagher Fiduciary Advisors LLC reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 8.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,144 shares of the healthcare conglomerate’s stock after selling 199 shares during the period. Gallagher Fiduciary Advisors LLC’s holdings in UnitedHealth Group were worth $1,032,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Stephens Inc. AR grew its position in UnitedHealth Group by 7.2% during the 2nd quarter. Stephens Inc. AR now owns 77,944 shares of the healthcare conglomerate’s stock valued at $37,463,000 after purchasing an additional 5,256 shares during the last quarter. Ergoteles LLC bought a new position in UnitedHealth Group in the 2nd quarter valued at approximately $2,642,000. Chilton Capital Management LLC increased its holdings in shares of UnitedHealth Group by 2.4% in the 2nd quarter. Chilton Capital Management LLC now owns 73,480 shares of the healthcare conglomerate’s stock worth $35,318,000 after purchasing an additional 1,742 shares in the last quarter. Sowell Financial Services LLC increased its holdings in UnitedHealth Group by 70.0% in the 2nd quarter. Sowell Financial Services LLC now owns 14,913 shares of the healthcare conglomerate’s stock worth $7,168,000 after buying an additional 6,141 shares in the last quarter. Finally, State of Wyoming lifted its stake in UnitedHealth Group by 94.0% during the 2nd quarter. State of Wyoming now owns 2,260 shares of the healthcare conglomerate’s stock valued at $1,086,000 after acquiring an additional 1,095 shares during the period. Institutional investors own 85.69% of the company’s stock.

UnitedHealth Group Stock Performance

UNH opened at $549.93 on Friday. The stock has a market capitalization of $508.64 billion, a price-to-earnings ratio of 23.87, a PEG ratio of 1.66 and a beta of 0.61. UnitedHealth Group Incorporated has a fifty-two week low of $445.68 and a fifty-two week high of $554.70. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.80 and a current ratio of 0.80. The company has a fifty day moving average of $534.81 and a 200 day moving average of $504.43.

UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Friday, October 13th. The healthcare conglomerate reported $6.56 EPS for the quarter, beating analysts’ consensus estimates of $6.33 by $0.23. The company had revenue of $92.36 billion during the quarter, compared to analyst estimates of $91.41 billion. UnitedHealth Group had a return on equity of 26.58% and a net margin of 6.02%. The firm’s revenue was up 14.2% on a year-over-year basis. During the same period in the prior year, the company earned $5.79 earnings per share. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 24.95 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, December 4th will be given a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a dividend yield of 1.37%. The ex-dividend date is Friday, December 1st. UnitedHealth Group’s dividend payout ratio is 32.64%.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on UNH. Stephens restated an “overweight” rating and issued a $585.00 target price on shares of UnitedHealth Group in a report on Thursday, November 30th. StockNews.com downgraded UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, October 21st. UBS Group upgraded shares of UnitedHealth Group from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $520.00 to $640.00 in a research note on Monday, October 16th. Jefferies Financial Group decreased their price target on shares of UnitedHealth Group from $565.00 to $503.00 and set a “hold” rating on the stock in a research report on Monday, November 20th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a report on Tuesday, November 21st. Two equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and an average price target of $578.05.

Check Out Our Latest Stock Report on UnitedHealth Group

Insider Buying and Selling

In other news, Director Stephen J. Hemsley sold 66,081 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, December 5th. The stock was sold at an average price of $550.39, for a total value of $36,370,321.59. Following the completion of the transaction, the director now owns 635,528 shares in the company, valued at approximately $349,788,255.92. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, Director Stephen J. Hemsley sold 121,515 shares of the business’s stock in a transaction on Tuesday, October 17th. The stock was sold at an average price of $540.58, for a total transaction of $65,688,578.70. Following the completion of the transaction, the director now owns 521,818 shares in the company, valued at approximately $282,084,374.44. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Stephen J. Hemsley sold 66,081 shares of the company’s stock in a transaction dated Tuesday, December 5th. The stock was sold at an average price of $550.39, for a total transaction of $36,370,321.59. Following the completion of the transaction, the director now owns 635,528 shares in the company, valued at $349,788,255.92. The disclosure for this sale can be found here. Over the last quarter, insiders sold 192,094 shares of company stock worth $104,507,072. Corporate insiders own 0.35% of the company’s stock.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).